[Use of phenobarbital, adenosine triphosphate and hemodesis in the treatment of hemolytic disease of newborn].
D000255:Adenosine Triphosphate / Q000627:therapeutic use*; D002118:Calcium / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004573:Electrolytes / Q000627:therapeutic use*; D004899:Erythroblastosis, Fetal / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008274:Magnesium / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use*; D011188:Potassium / Q000627:therapeutic use; D011205:Povidone / Q000627:therapeutic use*; D011247:Pregnancy; D012964:Sodium / Q000627:therapeutic use
D004573:Electrolytes; D000255:Adenosine Triphosphate; D012964:Sodium; D011205:Povidone; D008274:Magnesium; D011188:Potassium; D002118:Calcium; D010634:Phenobarbital
Opyt primeneniia fenobarbitala, adenozintrifosfornoĭ kisloty, gemodeza v terapii gemolitieheskoí bolezni novorozhdennykh.